MedElevator Войти в исследования
← Поиск публикаций

DOI 10.20517/2394-5079.2021.55

Медицинская библиотека · Hepatoma research · 2021

Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease.

Dong Tien S, Luu Kayti, Lagishetty Venu, Sedighian Farzaneh, Woo Shih-Lung, Dreskin Benjamin W, Katzka William, Chang Candace, Zhou Yi, Arias-Jayo Nerea, Yang Julianne, Ahdoot Aaron I, Ye Jason, Li Zhaoping, Pisegna Joseph R, Jacobs Jonathan P

СтатьяПеревод пока не подготовлен

Аннотация

AIM: The microbiome has been shown to be pivotal in the development of metabolic associated fatty liver disease (MAFLD). Few have examined the relationship of the microbiome specifically with steatosis grade. Therefore, our aim was to characterize the association of the microbiome with MAFLD steatosis severity while adjusting for metabolic comorbidities including diabetes.

METHODS

We enrolled patients with MAFLD at the West Los Angeles Veterans Affair Hospital. All patients underwent ultrasound elastography, fasting serum collection, and fecal sampling for 16S sequencing. We examined the associations of microbial diversity and composition with advanced steatosis, defined as a CAP score of ≥ 300 dB/m, with or without the presence of metabolic comorbidities.

RESULTS

Seventy-five patients were enrolled. African American were less likely to have advanced steatosis than either Hispanics or Whites (P = 0.001). Patients with more advanced steatosis had higher fasting serum triglyceride (192.6 ± 157.1 mg/dL vs. 122.5 ± 57.4 mg/dL), HbA1c (6.7% ± 1.4% vs. 6.1% ± 0.8%), transaminases, and were more likely to have metabolic syndrome (52.4% vs. 24.2%, P = 0.02). Advanced steatosis and diabetes were associated with altered microbial composition. Bacteroides was negatively associated with advanced steatosis while Megasphaera was positively associated with steatosis. Akkermansia was negatively associated with diabetes, while Anaerostipes and Parabacteroides were positively associated with diabetes.

CONCLUSION

Diabetes and metabolic syndrome are associated with hepatic steatosis severity in MAFLD patients and both advanced steatosis and comorbid diabetes are independently associated with microbiome changes. These results provide insight into the role of the gut microbiome in MAFLD associated with metabolic syndrome.

Для цитирования: Dong Tien S, Luu Kayti, Lagishetty Venu, Sedighian Farzaneh, Woo Shih-Lung, Dreskin Benjamin W, Katzka William, Chang Candace, Zhou Yi, Arias-Jayo Nerea, Yang Julianne, Ahdoot Aaron I, Ye Jason, Li Zhaoping, Pisegna Joseph R, Jacobs Jonathan P. Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease.. Hepatoma research. 2021. DOI: 10.20517/2394-5079.2021.55.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.